Logo image
Studies on segmented polyetherurethane for biomedical application: Effects of composition and hard-segment content on biocompatibility
Conference paper   Peer reviewed

Studies on segmented polyetherurethane for biomedical application: Effects of composition and hard-segment content on biocompatibility

Jui-Hsiang Chen, Jeng Wei, Chung-Yi Chang, Ru-Fong Laiw and YU-DER LEE
Journal of Biomedical Materials Research, Vol.41(4), pp.633-648
15/09/1998

Abstract

Blood compatibility Cell culture Cytotoxicity Hemolysis Segmented polyetherurethane (SPEU)
Segmented polyetherurethane (SPEU) materials based on polytetramethylene oxide (PTMO, Mw 1000 and 2000) with various hard-segment contents were synthesized and their biocompatibilities studied via different tests. The static contact angle data reveal that the higher hard-segment-content SPEU material possesses a lower contact angle, implying that the surface of the higher hard-segment-content SPEU is more hydrophilic than its low hard- segment-content SPEU counterpart. The catalyst- and additive-free PTMO-based SPEU materials in this study possess neither a hemolytic nor a cytotoxic response that could be considered non toxic for biomedical applications. By using L-929 cell lines, a cell-seeding test indicated that the higher hard- segment-content SPEU material possesses quicker cell attachment and proliferation behaviors. In vitro platelet adhesion tests indicated that the lower hard-segment-content SPEU possesses less platelet adhesion than the high hard-segment-content SPEU material. Both ex vivo canine artery-artery (A-A) and arterio-venous (A-V) shunting tests revealed that the extent of platelet adhesion reaction is less for lower hard-segment-content SPEU. In addition, the blood compatibility of SPEU material synthesized from PTMO 1000 excels over PTMO 2000 SPEU material by nearly the same levels as the hard- segment-content SPEU.

Metrics

1 Record Views

Details

Logo image